Paper10071354
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
Jain AB and 4 others. Liver Transpl Surg, 1999. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Papers, record 10071354. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10071354
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Liver Transplantation | Major topic |
| Tacrolimus | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Graft Rejection | |
| Humans | |
| Incidence | |
| Liver | |
| Longitudinal Studies | |
| Male | |
| Middle Aged | |
| Postoperative Complications | |
| Reoperation | |
| Survival Analysis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK029961 | NIDDK NIH HHS | United States | R01DK029961 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04763096 | Evaluate the Efficacy and Safety of the ADVAGRAF® | Results |
Source ClinicalTrials.gov
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21151749 | Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. | Clin Transplant | 1992 | https://conductscience.org/library/papers/21151749 | PubMed |
| 2 | 1703354 | Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1703354 | PubMed |
| 3 | 8696542 | The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. | J Am Coll Surg | 1996 | https://conductscience.org/library/papers/8696542 | PubMed |
| 4 | 9492860 | Higher incidence of diabetes in liver transplant recipients with hepatitis C. | J Clin Gastroenterol | 1998 | https://conductscience.org/library/papers/9492860 | PubMed |
| 5 | 9636567 | Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. | Transplant Proc | 1998 | https://conductscience.org/library/papers/9636567 | PubMed |
| 6 | 7491685 | Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. | Transplantation | 1995 | https://conductscience.org/library/papers/7491685 | PubMed |
| 7 | 1703340 | One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1703340 | PubMed |
| 8 | 7533358 | Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. | Transplant Proc | 1995 | https://conductscience.org/library/papers/7533358 | PubMed |
| 9 | 7522431 | Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. | Ann Surg | 1994 | https://conductscience.org/library/papers/7522431 | PubMed |
| 10 | 1689901 | Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. | Transplant Proc | 1990 | https://conductscience.org/library/papers/1689901 | PubMed |
| 11 | 6749635 | Evolution of liver transplantation. | Hepatology | 1982 | https://conductscience.org/library/papers/6749635 | PubMed |
| 12 | 1703682 | Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1703682 | PubMed |
| 13 | 3279643 | Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. | Transplant Proc | 1988 | https://conductscience.org/library/papers/3279643 | PubMed |
| 14 | 1721398 | Neurologic complications of FK 506. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1721398 | PubMed |
| 15 | 1689886 | Early trials with FK 506 as primary treatment in liver transplantation. | Transplant Proc | 1990 | https://conductscience.org/library/papers/1689886 | PubMed |
| 16 | 2478846 | FK 506 for liver, kidney, and pancreas transplantation. | Lancet | 1989 | https://conductscience.org/library/papers/2478846 | PubMed |
| 17 | 1721347 | Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1721347 | PubMed |
| 18 | 8442153 | De novo malignancy following liver transplantation: a single-center study. | Transplant Proc | 1993 | https://conductscience.org/library/papers/8442153 | PubMed |
| 19 | 9825817 | Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. | Transplantation | 1998 | https://conductscience.org/library/papers/9825817 | PubMed |
| 20 | 7520105 | Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. | Lancet | 1994 | https://conductscience.org/library/papers/7520105 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908604 | Out of sight, out of mind, but at high risk: incidence, timing and risk factors for hyperkalemia after liver transplant discharge. | Front Immunol | 2026 | https://conductscience.org/library/papers/42908604 | PubMed |
| 35769149 | Efficacy and safety of prolonged-release versus immediate-release tacrolimus in de novo liver transplant recipients in South Korea: a randomized open-label phase 4 study (MAPLE). | Korean J Transplant | 2019 | https://conductscience.org/library/papers/35769149 | PubMed |
| 33802465 | A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation. | J Clin Med | 2021 | https://conductscience.org/library/papers/33802465 | PubMed |
| 29947691 | PREVALENCE AND RISK FACTORS OF HYPERKALEMIA AFTER LIVER TRANSPLANTATION. | Arq Bras Cir Dig | 2018 | https://conductscience.org/library/papers/29947691 | PubMed |
| 27512161 | Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study. | Indian J Anaesth | 2016 | https://conductscience.org/library/papers/27512161 | PubMed |
| 26825098 | American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders. | Clin J Am Soc Nephrol | 2016 | https://conductscience.org/library/papers/26825098 | PubMed |
| 22555782 | An unusual complication of renal transplantation: a fistula between the sigmoid colon and the graft. | Updates Surg | 2013 | https://conductscience.org/library/papers/22555782 | PubMed |
| 12109922 | Single-agent immunosuppression after liver transplantation: what is possible? | Drugs | 2002 | https://conductscience.org/library/papers/12109922 | PubMed |
| 11005276 | The metabolic effects of cyclosporin and tacrolimus. | J Endocrinol Invest | 2000 | https://conductscience.org/library/papers/11005276 | PubMed |
| 10730553 | Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. | Drugs | 2000 | https://conductscience.org/library/papers/10730553 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| TACROLIMUS | CHEMBL3989887 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL3989887 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10071354
GET https://conductscience.org/api/papers/v1/10071354/references?page=2